 |
A novel therapeutic regime to eradicate established solid tumors with an effective indu... |
[2012-10-31] |
|
The tumor immunosuppressive microenvironment impairs the therapy of anti-HER2/neu antibody |
[2012-10-31] |
|
肿瘤免疫微环境在肿瘤常规治疗效应中的作用(特邀专家论坛栏目综述).中国肿瘤生物治疗杂志,201... |
[2012-10-31] |
|
The development and functions of CD4+ T cells expressing a transgenic TCR specific for ... |
[2012-10-31] |
|
B7-h2 is a costimulatory ligand for CD28 in human. |
[2012-10-31] |
|
Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver ... |
[2012-10-31] |
|
CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepat... |
[2012-10-31] |
|
Development and characterization of monoclonal antibodies against mouse TSLP. |
[2012-10-31] |
|
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive im... |
[2012-10-31] |
|
Association between hepatitis B viral burden in chronic infection and a functional sing... |
[2012-10-31] |
|
Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disea... |
[2012-10-31] |
|
Structural immunology of costimualtory and coinhibitory molecules. |
[2012-10-31] |
|
Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal pathways. |
[2012-10-31] |
|
CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection. |
[2012-10-31] |
|
PD-1 on dendritic cells impedes innate immunity against bacterial infection. |
[2012-10-31] |
|
Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modi... |
[2012-10-31] |
|
B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune f... |
[2012-10-31] |
|
Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tum... |
[2012-10-31] |
|
Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vac... |
[2012-10-31] |
